Hepatitis B virus e antigen and primary hepatocellular carcinoma
- PMID: 1663719
Hepatitis B virus e antigen and primary hepatocellular carcinoma
Abstract
Serum samples from 243 cases of primary hepatocellular carcinoma (PHC) and 302 non-PHC hospital controls were tested for hepatitis B virus (HBV) surface antigen (HBsAg), antibody to HBsAg (anti-HBs), antibody to HBV core antigen (anti-HBc), HBV e antigen (HBeAg) and antibody to HBeAg (anti-HBe) with radioimmunoassays using commercial kits. A total of 236 (97%) PHC cases and 302 (100%) hospital controls were positive for one or more HBV markers. While 188 (77%) PHC cases and 57 (19%) controls were positive for HBsAg, 44 (18%) PHC cases and 5 (2%) controls were positive for both BHsAg and HBeAg. Statistically significant associations with PHC were observed for HBsAg and HBeAg with an odds ratio (OR) of 10.0 and 3.2, respectively, when age, sex and other markers were adjusted. The stratification analysis of interactive effects of HBV infection markers on the development of PHC showed that HBeAg carrier status may increase PHC risk associated with HBsAg status.
Similar articles
-
Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.J Natl Cancer Inst. 1981 Mar;66(3):475-9. J Natl Cancer Inst. 1981. PMID: 6162990
-
Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.Singapore Med J. 1996 Oct;37(5):492-6. Singapore Med J. 1996. PMID: 9046201
-
Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17. J Natl Cancer Inst. 2009. PMID: 19535774
-
[Seroconversion of HBs antigen to anti-HBs].Nihon Rinsho. 2004 Aug;62 Suppl 8:88-92. Nihon Rinsho. 2004. PMID: 15453293 Review. Japanese. No abstract available.
-
The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.Med Microbiol Immunol. 2011 Feb;200(1):13-22. doi: 10.1007/s00430-010-0160-3. Epub 2010 May 11. Med Microbiol Immunol. 2011. PMID: 20458499 Review.
Cited by
-
Epidemiology and Prevention of Hepatitis B Virus Infection.Int J Med Sci. 2005;2(1):50-57. doi: 10.7150/ijms.2.50. Epub 2005 Jan 5. Int J Med Sci. 2005. PMID: 15968340 Free PMC article.
-
Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.Br J Cancer. 1996 Jun;73(12):1498-502. doi: 10.1038/bjc.1996.283. Br J Cancer. 1996. PMID: 8664119 Free PMC article.
-
Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.PLoS One. 2019 Aug 8;14(8):e0220663. doi: 10.1371/journal.pone.0220663. eCollection 2019. PLoS One. 2019. PMID: 31393964 Free PMC article.
-
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Hepatol Int. 2010 Mar 18;4(2):439-74. doi: 10.1007/s12072-010-9165-7. Hepatol Int. 2010. PMID: 20827404 Free PMC article.
-
Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma.World J Gastroenterol. 2014 May 28;20(20):5999-6005. doi: 10.3748/wjg.v20.i20.5999. World J Gastroenterol. 2014. PMID: 24876722 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical